Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities

Launched by M.D. ANDERSON CANCER CENTER · Feb 8, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at how different types of follow-up care after surgery affect anxiety levels in patients with stage II-III soft tissue sarcoma, which is a type of cancer that can occur in the trunk and limbs. The study compares two approaches: limited follow-up, where patients visit the doctor less often, and intense follow-up, which involves more frequent check-ups. Researchers want to see if the amount of follow-up care influences how anxious patients feel after their treatment and whether it impacts their overall well-being.

To participate in this trial, you need to be at least 18 years old and have recently completed treatment for sarcoma, such as surgery, chemotherapy, or radiation therapy, within the last 8 to 14 weeks. You should also be willing to fill out surveys for two years. Patients who have cancer that has spread to other parts of the body or who do not speak English are not eligible to join. Pregnant women can participate in this study. If you join, you can expect to share your experiences and feelings about your care and how it affects your anxiety and quality of life over time.

Gender

ALL

Eligibility criteria

• IInclusion Criteria:
• • ≥18 years old
• • Completion of sarcoma therapy (chemotherapy, radiation therapy and/or surgery) within 8-14 weeks of study enrollment
• • Willingness to complete surveys x 2 years
• Exclusion Criteria:
• • Documented metastatic disease at the time of enrollment
• • Non-English-speaking patients
• • Pregnant women will be included in this clinical trial.